Health Care: Drugs

Acorda Therapeutics Inc (ACOR: NASDAQ)

$14.25 n/a | n/a%
05/26/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 519.60M 492.66M 401.48M 336.43M
Cost of Sales 76.34M 65.98M 64.25M 57.07M
Gross Operating Profit 443.26M 426.68M 337.23M 279.36M
Selling, General, and Administrative Expenses 235.44M 205.63M 201.81M 185.54M
Research & Development 203.44M 149.21M 73.47M 53.88M
Operating Income before D & A (EBITDA) 4.38M 71.84M 61.94M 39.94M
Depreciation & Amortization 31.77M 26.95M 16.36M 9.57M
Interest Income 339.00K 440.00K 674.00K 668.00K
Other Income - Net 9.90M 411.00K 232.00K 0.00
Special Income / Charges -8.60M -10.90M -9.19M 0.00
Total Income Before Interest Expenses (EBIT) -25.74M 34.84M 37.30M 31.03M
Interest Expense 16.53M 15.47M 9.29M 2.17M
Pre-Tax Income -42.27M 19.37M 28.01M 28.86M
Income Taxes -6.67M 8.31M 10.34M 12.42M
Minority Interest -985.00K 0.00 0.00 0.00
Net Income From Continuing Operations -35.60M 11.06M 17.67M 16.44M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -35.60M 11.06M 17.67M 16.44M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -34.62M 11.06M 17.67M 16.44M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-27.00M 21.96M 26.86M 16.44M
Preferred Dividends
Net Income Available To Common -35.60M 11.06M 17.67M 16.44M
Basic EPS from Continuing Ops. -0.76 0.26 0.43 0.41
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.76 0.26 0.43 0.41
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.76 0.26 0.43 0.41
Basic Normalized Net Income/Share -0.58 0.52 0.65 0.41
EPS fr Continuing Ops. -0.76 0.25 0.42 0.39
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.76 0.25 0.42 0.39
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.76 0.25 0.42 0.39
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.58 0.50 0.64 0.39
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACOR

Latest ACOR Headlines from TheStreet

More Financial News for ACOR

Press Releases for ACOR

See All Press Releases

Partner Headlines for ACOR

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter